Chapter 50- Urinary Incontinence and Pediatric Enuresis

Description:
IMPORTANT NOTE – PLEASE READ FIRST: This continuing education assessment requires that you first purchase the text book: Pharmacotherapy Principles & Practice. Please go to our home page: http://www.rxugace.com/ and click on “Books” for more information Prior To Registering for this assessment.

Upon completion of the corresponding textbook chapter in Pharmacotherapy Principles & Practice and this on-line assessment, the reader should be able to:

1. Explain the pathophysiology of the major types of urinary incontinence (urge, stress, overflow, and functional) and pediatric enuresis.
2. Recognize the signs and symptoms of the major types of urinary incontinence and pediatric enuresis in individual patients.
3. List the treatment goals for a patient with urinary incontinence or pediatric enuresis.
4. Compare and contrast anticholinergic/antispasmodics, -adrenoceptor agonists, dual serotonin-norepinephrine reuptake inhibitors, vaginal estrogens, cholinomimetics, tricyclic antidepressants, and vasopressin analogues in terms of mechanism of action, treatment outcomes, adverse effects, and drug-drug interaction potential when used to manage urinary incontinence or pediatric enuresis.
5. Identify factors that guide drug selection for an individual patient.
6. Formulate a monitoring plan for a patient on a given treatment regimen based on patient-specific information.
7. Describe indicators for combination drug therapy of urinary incontinence or pediatric enuresis.
8. Describe nonpharmacologic treatment approaches (including surgery) for urinary incontinence or pediatric enuresis.
9. Formulate appropriate patient counseling information for patients undergoing drug therapy for urinary incontinence or pediatric enuresis.

Courses Offered